Oliver Rausch

 Oliver Rausch
Oliver Rausch
Chief Scientific Officer
Storm Therapeutics Ltd

Presentations at Drug Discovery 2021 After the Storm: Re-connect, Re-invent, Re-imagine

Tue19  Oct10:50am(10 mins)

Session: Innovations in Chemistry to Discover New Medicines: Approaches to Drugging RNA
Room: Hall 1B

Profile of Oliver Rausch

Oliver Rausch is Chief Scientific Officer at Storm Therapeutics Ltd. Storm is a spin-out from Cambridge University targeting RNA modification pathways for the development of a new class of anti-cancer treatments. As CSO, Oliver has overall responsibility for developing Storm’s RNA modification analysis platform, and for delivering small molecule drugs from its emerging drug discovery pipeline.

Prior to Storm, Oliver was Programme Director at the National Institute for Health Research (NIHR) where he led the Translational Research Partnerships (TRPs) and other industry-focussed clinical collaboration programmes in experimental medicine and early drug development.

Oliver has over twenty years of drug discovery experience in Inflammation, Neurology and Oncology from organisations such as GlaxoSmithKline, UCB Celltech and Cellzome. He holds a degree in Biochemistry from the Free University in Berlin and a PhD in Biochemistry and Cell Biology from the Institute of Cancer Research in London.


Dr Dan Leggate
Head of Discovery Biology
Storm Therapeutics Ltd


Please login to send a Private Message

Hosted By

The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo Find us on Facebook Follow us on Twitter

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
Eventflo Home
copyright ELRIG, eventflo.co.uk, Labhoo Ltd 2003-2021